Page 2 of 3
Results 76 - 150 of 202
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Beyond The Basics Of PAH
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
COVID-19 Associated ARDS
No image set
COVID-19 and Comorbid ILD
No image set
Three Cases of Lung Fibrosis in Patients With COVID-19
No image set
Assessing a Patient With Long COVID-19
No image set
COVID-19 Acute and Long-term Lung Injury
No image set
COVID-19: An Animated Video Series
No image set
COVID-19 and ARDS: East Coast Experiences
No image set
IPF Animated Video Series: Micro-learning focusing on the soft skills
No image set
Practical Applications From What We Heard at Virtual ACR
No image set
Learning From SARS and MERS: What Should We Expect for COVID-19 Patients
No image set
COVID-19 and Lung Injury/Fibrosis
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan to Manage IPF
No image set
Diagnosis of Interstitial Lung Disease
No image set
Allergic Asthma: Virtual Conference Coverage
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Learnings From the Virtual ERS International Congress
No image set
Practical Questions in the Diagnosis and Management of Patients With MAC
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
9165 product
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Managing the Whole Patient with COPD: An Animated Video Series
No image set
My COPD Action Plan
No image set
Expert Recommendations for COPD
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
No image set
Understanding the Endocannabinoid System (Cystic Fibrosis)
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
No image set
COPD: Proper Inhaler Use
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
No image set
Pulmonologists as the Gatekeepers of Precision Medicine
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
No image set
How to Identify & Manage Patients with Progressive-Fibrosing ILD
9840-0004-icon
Acute Exacerbations of IPF
9916-cme-icon
Personalized Medicine for Improving Asthma Care: An Animated Video Series
9815-developments
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9815-palliative slides
Palliative Medicine in Pulmonology
No image set
Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation
No image set
Dyspnea and Disease are Progressing: What to Do?
Page 2 of 3